Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Tselmin, S.
19  Ergebnisse:
Personensuche X
?
1

Asymmetric dimethylarginine (ADMA) mediates the effect of m..:

Jarzebska, N. ; Tselmin, S. ; Kleber, M.E....
Atherosclerosis.  355 (2022)  - p. 52-53 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Asymmetric dimethylarginine (ADMA) mediates the effect of m..:

Tselmin, S. ; Kleber, M. ; Jarzebska, N....
Atherosclerosis.  331 (2021)  - p. e222 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Homoarginine supplementation in patients with heart failure..:

Tselmin, S. ; Jarzebska, N. ; Rodionov, R..
Atherosclerosis.  315 (2020)  - p. e229 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Lipoprotein(a)—an interdisciplinary challenge:

Julius, U. ; Tselmin, S. ; Schatz, U...
Clinical Research in Cardiology Supplements.  14 (2019)  S1 - p. 20-27 , 2019
Link: https://doi.org/10.1007/..
 
?
5

Lipoprotein(a) and proprotein convertase subtilisin/kexin t..:

Julius, U. ; Tselmin, S. ; Schatz, U...
Clinical Research in Cardiology Supplements.  14 (2019)  S1 - p. 45-50 , 2019
Link: https://doi.org/10.1007/..
 
?
6

Kinetics of Lipoprotein(a) in patients undergoing weekly li..:

Tselmin, S. ; Müller, G. ; Schatz, U....
Atherosclerosis Supplements.  30 (2017)  - p. 209-216 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Lipoprotein apheresis influences monocyte subpopulations:

Jellinghaus, S. ; Reich, C. ; Schatz, U....
Atherosclerosis Supplements.  30 (2017)  - p. 108-114 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Most significant reduction of cardiovascular events in pati..:

Schatz, U. ; Tselmin, S. ; Müller, G....
Atherosclerosis Supplements.  30 (2017)  - p. 246-252 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Cardiovascular events in patients treated by lipoprotein ap..:

Tselmin, S. ; Fischer, S. ; Pistrosch, F...
Atherosclerosis.  252 (2016)  - p. e215-e216 , 2016
Link: https://doi.org/10.1016/..
 
?
10

Elevated lipoprotein(a) levels result in a high cardiovascu..:

Schatz, U. ; Fischer, S. ; Julius, U...
Atherosclerosis.  252 (2016)  - p. e127-e128 , 2016
Link: https://doi.org/10.1016/..
 
?
11

An elevated lipoprotein(a) plasma level as a cardiovascular..:

Tselmin, S. ; Müller, G. ; Gelgaft, E...
Atherosclerosis Supplements.  18 (2015)  - p. 257-262 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Hypertriglyceridemia in an outpatient department – Signific..:

Scholz, M. ; Tselmin, S. ; Fischer, S..
Atherosclerosis Supplements.  18 (2015)  - p. 146-153 , 2015
Link: https://doi.org/10.1016/..
 
?
13

Lipoprotein(a) als Arteriosklerose-Risikofaktor:

Fischer, S. ; Julius, U. ; Tselmin, S...
DMW - Deutsche Medizinische Wochenschrift.  139 (2014)  23 - p. 1204-1206 , 2014
Link: https://doi.org/10.1055/..
 
?
14

Effects of lipoprotein apheresis (la) on serum homocysteine..:

Julius, U. ; Tselmin, S. ; Rodionov, R.N..
Atherosclerosis.  235 (2014)  2 - p. e63 , 2014
Link: https://doi.org/10.1016/..
 
?
15

Homocysteine in lipoprotein apheresis patients – Retrospect..:

Tselmin, S. ; Rodionov, R.N. ; Müller, G...
Atherosclerosis Supplements.  14 (2013)  1 - p. 123-128 , 2013
Link: https://doi.org/10.1016/..
 
1-15